New insights into the role of Kallikrein proteases in cancer

March 1, 2016

Kallikrein-related peptidase 2 (KLK2) is a key serine protease involved in the metastatic progression of prostate cancer. The Brandstetter lab now identified that post-translation modification of KLK2 by glycosylation regulates its activation and enzymatic activity. These striking effects of glycosylation pave the way to a deeper understanding of kallikrein-related peptidase function in malignant progression. The study by Shihui Guo et al. has been published  in the Journal of Biological Chemistry and can be found here

Please reload

 Recommended News 

Salzburg Breast Cancer Meeting - Mastering Translational Immuno-Oncology

January 13, 2017

Please reload

 Recent News 
Please reload